drugset / Trial / NCT00222651

Tenecteplase Pulmonary Embolism Italian Study

NCT00222651

Phase 2 Terminated 180 enrolled University Of Perugia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To assess the efficacy and safety of Tenecteplase versus Placebo in normotensive patients with sub-massive Pulmonary Embolism and Right Ventricular Dysfunction (RVD) all receiving unfractionated heparin (UFH)

Timeline

Start
2004-07
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenecteplase Protein / enzyme biologic Intravenous

Indications